Biological Activity
RG3039 (PF-06687859) is an orally bioavailable and brain-penetrant DcpS inhibitor with an IC50 of 0.069 nM.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.13 mL | 115.65 mL | 231.29 mL |
0.5 mM | 4.63 mL | 23.13 mL | 46.26 mL |
1 mM | 2.31 mL | 11.56 mL | 23.13 mL |
5 mM | 0.46 mL | 2.31 mL | 4.63 mL |
*The above data is based on the productmolecular weight 432.35. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A12642 |
---|---|
Actions | Inhibitor |
M. Wt | 432.35 |
Formula | C21H23Cl2N5O |
Solubility | DMSO |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1005504-62-0 |
Synonyms | RG 3039, RG-3039, PF-06687859, PF06687859, PF 06687859 |
SMILES | NC1=NC(N)=C2C(OCC3CCN(CC4=C(Cl)C=CC=C4Cl)CC3)=CC=CC2=N1 |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy RG3039 | RG3039 Supplier | purchase | cost | manufacturer | order | distributor | buy 1005504-62-0| 1005504-62-0 Supplier | purchase 1005504-62-0 | 1005504-62-0 cost | 1005504-62-0 manufacturer | order 1005504-62-0 | 1005504-62-0 distributor